Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
7.13
-0.32 (-4.32%)
At close: May 12, 2025, 4:00 PM
7.90
+0.77 (10.83%)
After-hours: May 12, 2025, 7:35 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $185.44 million as of May 12, 2025.
Market Cap
185.44M
Enterprise Value
216.94M
1-Year Change
n/a
Ranking
Category
Stock Price
$7.13
Market Cap Chart
Since August 9, 2024, Liminatus Pharma's market cap has decreased from $1.24B to $185.44M, a decrease of -85.03%. That is a compound annual growth rate of -92.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 193.81M | -84.61% |
| Dec 31, 2024 | 1.26B | 1.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |